From MarketBeat:

Slow Capital Inc. decreased its stake in Insulet Co. (NASDAQ:PODD) by 50.3% during the third quarter, reducing their shares to 5,010 which were worth $799,000. Other institutional investors also made changes. In related news, director Shacey Petrovic sold 20,000 shares at $164.33 each. Insulet trading down 1.1% on Friday.

Wall Street analysts have weighed in on the company, with five rating it as a hold and thirteen as a buy. The stock currently has an average rating of “Moderate Buy” and an average price target of $259.33. Insulet Co. will post 1.91 earnings per share for the fiscal year.

Insulet Corporation offers insulin delivery systems for people with insulin-dependent diabetes. Their Omnipod System is a disposable tubeless device that can be worn for up to 3 days, along with a handheld diabetes manager.

Insulet currently has a “Moderate Buy” rating among analysts, but top-rated analysts believe that the five stocks they are recommending are better buys. Insulet didn’t make the list, but these stocks are considered to be better investments.



Read more: Slow Capital Inc. Cuts Holdings in Insulet Co. (NASDAQ:PODD)